The Growth of Biosimilars Continues to Create Hope for Lower Drug Costsccaplan7Aug 28, 20231 min readBefore a once-in-a-generation pandemic struck the globe, adalimumab (Humira; AbbVie) was the most profitable drug in the world...Read full story